Do β-adrenoreceptor blocking drugs associate with reduced risk of symptomatic osteoarthritis and total joint replacement in the general population? A primary care-based, prospective cohort study using the Clinical Practice Research Datalink
Introduction To investigate if β-adrenoreceptor blocking drug (β-blocker) prescription reduces the risk of knee or hip osteoarthritis, total joint replacement and analgesic prescription.Setting Primary care.Methods and analysis This is a cohort study using data from the Clinical Practice Research Da...
Saved in:
| Main Authors: | Mamas A Mamas, Christian Mallen, Abhishek Abhishek, Michael Doherty, Nick Townsend, Weiya Zhang, Georgina Nakafero, Matthew Grainge, Ana Valdes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-08-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/9/8/e032050.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ADRENORECEPTORS BLOCKING: RECENT DATA ON URAPIDIL USAGE
by: O. Yu. Shaydyuk, et al.
Published: (2015-09-01) -
Morphological variations at the knee associated with osteoarthritis: a case-control study using data from the GOAL study
by: Anand Ramachandran Nair, et al.
Published: (2023-06-01) -
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
by: Abhishek Abhishek, et al.
Published: (2024-02-01) -
Prophylactic cervical cerclage, fully embedded, for twin pregnancies following fertility treatment
by: L. Mamas, et al.
Published: (2020-04-01) -
Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
by: D. V. Duplyakov
Published: (2009-08-01)